Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 11, 2026
Why Is First Advantage (FA) Stock Down -12.17% Today?

Why Is First Advantage (FA) Stock Down -12.17% Today?

Key Takeaways

  • First Advantage shares tumbled 12.17% in early trading Tuesday, sliding from Friday's close of $23.59 to around $20.72.
  • The primary catalyst: a regulatory filing disclosed that existing shareholders plan to resell up to 87.45 million shares, representing roughly 51% of total shares outstanding.
  • The company itself is not issuing new shares and will receive no proceeds from the sale, but the sheer size of the potential overhang rattled investors.
  • The selloff comes just days after the stock surged on stellar Q2 results, creating a sharp reversal from post-earnings highs above $24.
  • Traders are now monitoring whether the secondary offering proceeds smoothly and whether the company's strong fundamentals can stabilize the stock once selling pressure subsides.

Opening Summary

Shares of FA, First Advantage Corporation — a global provider of employment background screening, digital identity verification, and HR technology solutions — plunged 12.17% in Tuesday's trading session, falling to $20.72 from the previous session's close of $23.59. The decline was triggered by a disclosure that certain existing stockholders intend to sell a massive block of up to 87.45 million common shares in a secondary offering, raising the specter of significant near-term supply pressure on the stock.

Massive Secondary Offering Sparks Selling Panic

The overwhelming driver behind Tuesday's double-digit decline is a regulatory filing made after Friday's close, revealing that existing shareholders may resell up to 87.45 million shares of FA. With approximately 171.75 million shares outstanding, the potential offering represents roughly 51% of the company's total float — an unusually large secondary transaction that caught the market off guard.

Importantly, First Advantage itself is not participating in the offering and will not receive any cash proceeds. The selling stockholders appear to be seeking liquidity or rebalancing their holdings. Nevertheless, the scale of the potential share dump created immediate selling pressure: shares were already down over 8% in after-hours trading Friday evening, and the weakness accelerated into Tuesday's regular session.

Secondary offerings of this magnitude often weigh on share prices because they signal that large insiders or early investors are looking to exit — and because a flood of new shares hitting the market can temporarily overwhelm demand, even when the underlying business remains healthy.

Sharp Reversal from Post-Earnings Highs

The selloff marks a dramatic reversal from the stock's trajectory just last week. On August 6, FA shares surged 17.3% after the company reported exceptional second-quarter results. Revenue climbed 15% year-over-year to $448.8 million, comfortably beating analyst expectations, while adjusted EPS of $0.35 surpassed the $0.29 consensus. Management also raised full-year guidance, projecting revenue of $1.67 billion to $1.71 billion and adjusted diluted EPS of $1.23 to $1.29.

The post-earnings rally pushed shares as high as $25.15 intraday on August 7. Since that peak, the stock has now shed roughly 18% in just three trading sessions — a whiplash that underscores how quickly sentiment can shift when a large supply overhang emerges, even against a backdrop of strong operational performance.

Market Context and Trading Activity

Trading volume in FA is running significantly above average on Tuesday, reflecting the urgency with which some shareholders are repositioning. The stock's average daily volume sits around 1.8 million shares, and Tuesday's session is on track to far exceed that figure.

The decline in FA is company-specific rather than sector-driven. Broader markets have shown relative stability, and peer companies in the specialty business services and HR technology segments have not experienced comparable moves. The selloff is being interpreted by the market as a technical supply event rather than a repricing of the company's fundamental value.

From a technical standpoint, the stock has sliced through several near-term support levels, including the pre-earnings consolidation range near $21-$22. The rapid drop means FA has now surrendered most of its post-earnings gains, returning to levels last seen in early August before the Q2 report.

What Comes Next for FA

The immediate question for FA investors is how the secondary offering will be executed and absorbed. If selling shareholders price the offering at a modest discount and demand proves sufficient, the stock could stabilize relatively quickly. Conversely, if the offering process drags on or is poorly received, the overhang could persist for weeks.

Beyond the near-term supply event, First Advantage's business fundamentals remain intact. The company posted its fourth consecutive quarter of positive year-over-year revenue growth, retains 96% of its customers, and is gaining traction with its AI-powered digital identity solutions. Its diversified vertical exposure across retail, transportation, healthcare, and gig economy hiring provides resilience against sector-specific downturns. However, management has cautioned that growth rates may moderate in the second half of 2026 due to tougher comparisons and ongoing macroeconomic uncertainty.

Investors will likely watch for any updates on the secondary offering's pricing and completion timeline, as well as the company's next earnings report expected in early November. The stock's elevated trailing P/E ratio of approximately 160 also leaves it vulnerable to further multiple compression if sentiment remains cautious.

Trending AI Robots

In volatile market conditions like those affecting FA today, traders often turn to AI-driven tools to navigate uncertainty. Tickeron's Trending AI Robots page features a curated selection of AI trading bots designed to identify opportunities across thousands of tickers. Only the strongest performers — those demonstrating consistent results under current market conditions — are highlighted in this section. Bots vary by strategy, timeframe, performance metrics, and the symbols they trade, allowing users to find approaches aligned with different risk profiles and investment styles. Explore the Trending AI Robots page to discover data-driven strategies suited to today's market environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FA

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


FA's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for FA turned positive on August 06, 2026. Looking at past instances where FA's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 05, 2026. You may want to consider a long position or call options on FA as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FA advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where FA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FA broke above its upper Bollinger Band on August 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.131) is normal, around the industry mean (7.665). P/E Ratio (157.267) is within average values for comparable stocks, (66.592). FA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.524). FA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (2.464) is also within normal values, averaging (9.077).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Industry description

The industry produces equipment regularly used in offices by businesses and other organizations, and could range from items like Blank sheet paper, calendars, Label and adhesive paper, paper clips, janitorial supplies, to larger /higher cost products like computers, printers, photocopiers, office furniture and so on. Many businesses in the office supply industry have been expanding into related markets like business cards, plus printing and binding of high quality, high volume business and engineering documents. Some companies in this industry also offer shipping services, including packaging and bulk mailing. Herman Miller, Inc., Steelcase Inc. and HNI Corporation.

Market Cap

The average market capitalization across the Office Equipment/Supplies Industry is 7.72B. The market cap for tickers in the group ranges from 359.74K to 89.97B. MCHSF holds the highest valuation in this group at 89.97B. The lowest valued company is JFIL at 359.74K.

High and low price notable news

The average weekly price growth across all stocks in the Office Equipment/Supplies Industry was -1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 4%. TIC experienced the highest price growth at 32%, while THH experienced the biggest fall at -87%.

Volume

The average weekly volume growth across all stocks in the Office Equipment/Supplies Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 54
Price Growth Rating: 56
SMR Rating: 73
Profit Risk Rating: 84
Seasonality Score: -36 (-100 ... +100)
View a ticker or compare two or three
FA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry OfficeEquipmentSupplies

Profile
Details
Industry
N/A
Address
1 Concourse Parkway NE
Phone
+1 678 868-4151
Employees
9500
Web
https://www.fadv.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.